Analystreport

Acorda Therapeutics (NASDAQ: ACOR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors